NVS TSX · · FY 2025-12-31

Novartis CDR (CAD Hedged)

Back to TSX
0.025.851.677.3103.1ABVnot valid for this companyEPVfair 95.48buy ≤ 42.97EBVfair 24.09buy ≤ 10.84DBVfair 7.04buy ≤ 3.87price 21.50 USD
0.036.372.6108.9145.2ABVnot valid for this companyEPVfair 134.40buy ≤ 60.48EBVfair 33.91buy ≤ 15.26DBVfair 9.90buy ≤ 5.45price 30.26 CAD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USDCAD
Verdict
Buy
Buy zone
Earnings Floor Buy
Archetype
Asset-Light Compounder
Confidence
●●● High · 3/4
Price
21.49730.260 USDCAD *
Market cap
41.02B57.74B USDCAD *
P / B
0.89
P / E
20.15
EPS
1.0671.502
DPS / yield
0.4020.566 (1.9%)
NAV / share
-4.417-6.218
Graham number
24.09233.913
Z'' score
—
Piotroski F
8 / 9
Beneish M
-2.50
ROIC vs WACC
21.3% vs 7.2%

* Listed in CAD — the pipeline states price and all valuations in the filing currency USD (fx 0.71 USD/CAD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.